Matrix Capital Management Company’s Aura Biosciences AURA Stock Holding History

Matrix Capital Management Company’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,922,870	Closed	-$46.3M	–	1
2026 Q1	$46.3M	Hold	6,922,870	–	–	100%	1
2025 Q4	$37.7M	Hold	6,922,870	–	–	65.48%	1
2025 Q3	$42.8M	Hold	6,922,870	–	–	40.08%	2
2025 Q2	$43.3M	Hold	6,922,870	–	–	19.45%	2
2025 Q1	$40.6M	Hold	6,922,870	–	–	11.68%	2
2024 Q4	$56.9M	Hold	6,922,870	–	–	2.65%	4
2024 Q3	$61.7M	Hold	6,922,870	–	–	2.94%	4
2024 Q2	$52.3M	Hold	6,922,870	–	–	0.4%	17
2024 Q1	$54.3M	Hold	6,922,870	–	–	0.5%	18
2023 Q4	$61.3M	Buy	6,922,870 +1,560,000	+29%	+$13.2M	0.63%	13
2023 Q3	$48.1M	Hold	5,362,870	–	–	0.58%	15
2023 Q2	$66.2M	Hold	5,362,870	–	–	0.77%	14
2023 Q1	$49.8M	Hold	5,362,870	–	–	0.68%	14
2022 Q4	$56.3M	Buy	5,362,870 +1,250,000	+30%	+$15.9M	1.08%	15
2022 Q3	$74.5M	Hold	4,112,870	–	–	1.43%	15
2022 Q2	$58.3M	Hold	4,112,870	–	–	1.32%	15
2022 Q1	$90.5M	Hold	4,112,870	–	–	1.09%	18
2021 Q4	$69.8M	Buy	+4,112,870	New	+$73.5M	0.78%	20

Other funds holding AURA

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Matrix Capital Management Company's AURA Position: Q2 2026 in Review

Matrix Capital Management Company sold out of Aura Biosciences (AURA) in Q2 2026, closing a stake of 6,922,870 shares — an estimated $46.3M sold.

Matrix Capital Management Company first reported a position in AURA in Q4 2021 and held it in 18 quarters. The position peaked at $90.5M in Q1 2022. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

Matrix Capital Management Company reported no remaining Aura Biosciences position as of Q2 2026 after selling out during the quarter.
Matrix Capital Management Company sold 6,922,870 Aura Biosciences shares in Q2 2026, an estimated $46.3M.
Matrix Capital Management Company first reported a position in Aura Biosciences in Q4 2021 and held it in 18 quarters.
Matrix Capital Management Company's Aura Biosciences position peaked at $90.5M in Q1 2022.
146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Matrix Capital Management Company's 13F filing for Q2 2026.